GLP-1 Receptor Agonists & Lower Dementia Risk in Older Adults with Diabetes (2024 Study)

TLDR: GLP-1 agonists were found to significantly reduce the risk of dementia in older individuals with type 2 diabetes mellitus (T2DM) compared to DPP-4 inhibitors and sulfonylureas. Highlights: A sequential trial emulation was conducted using data from Swedish national registers from 2010 to 2020, involving 88,381 participants aged 65 or older with T2DM. The incidence …

Read more

Pharmacogenomics: Genetics Determine Weight Gain & Loss from Drugs & Medications

Obesity has reached epidemic levels globally, with serious health and economic consequences. While lifestyle factors play a key role, genetics also influence a person’s susceptibility to weight gain or difficulty losing weight. An emerging field called pharmacogenomics is uncovering how genetics impacts response to medications that cause weight gain as a side effect, as well …

Read more